Literature DB >> 2767708

Reversible injury of cultured rat oligodendrocytes by complement.

N J Scolding1, W A Houston, B P Morgan, A K Campbell, D A Compston.   

Abstract

Rat oligodendrocytes are lysed on exposure to normal homologous serum as a result of classical pathway complement activation and attack in the absence of anti-myelin antibodies. The effect of non-lethal complement attack on oligodendrocytes in vitro was studied by exposing dissociated neonatal rat optic nerve cell cultures to low concentrations of complement alone and also in the presence of oligodendrocyte-specific monoclonal antibodies. Regardless of the mode of complement activation, non-lethal complement attack led to reversible cell injury, recovery following a transient rise in intracellular calcium and fall in ATP in the absence of membrane permeabilization to propidium iodide. A single episode of non-lethal injury had no effect on the ability of oligodendrocytes subsequently to express cell-specific antigens, but repeated episodes had a cumulative effect and ultimately resulted in cell death. Reversible and/or lytic complement-mediated oligodendrocyte injury has implications for the pathogenesis of human and experimental demyelinating diseases.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2767708      PMCID: PMC1385311     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  30 in total

1.  Metabolism of phosphate and sulfate groups modifying the P0 protein of peripheral nervous system myelin.

Authors:  A D Toews; H R Fischer; J F Goodrum; S Windes; P Morell
Journal:  J Neurochem       Date:  1987-03       Impact factor: 5.372

2.  Proteolytic activity and basic protein loss in and around multiple sclerosis plaques: combined biochemical and histochemical observations.

Authors:  E R Einstein; J Csejtey; K B Dalal; C W Adams; O B Bayliss; J F Hallpike
Journal:  J Neurochem       Date:  1972-03       Impact factor: 5.372

3.  Kinetics of the firefly luciferase catalyzed reactions.

Authors:  M DeLuca; W D McElroy
Journal:  Biochemistry       Date:  1974-02-26       Impact factor: 3.162

4.  Release of leukotriene B4 from sublethally injured oligodendrocytes by terminal complement complexes.

Authors:  Y Shirazi; D K Imagawa; M L Shin
Journal:  J Neurochem       Date:  1987-01       Impact factor: 5.372

Review 5.  Remyelination in the central nervous system and the peripheral nervous system.

Authors:  S K Ludwin
Journal:  Adv Neurol       Date:  1988

6.  Normal rat serum cytotoxicity against syngeneic oligodendrocytes. Complement activation and attack in the absence of anti-myelin antibodies.

Authors:  N J Scolding; B P Morgan; A Houston; A K Campbell; C Linington; D A Compston
Journal:  J Neurol Sci       Date:  1989-02       Impact factor: 3.181

7.  Hydrolysis of myelin basic protein in human myelin by terminal complement complexes.

Authors:  P Vanguri; M L Shin
Journal:  J Biol Chem       Date:  1988-05-25       Impact factor: 5.157

8.  Myelin-oligodendrocyte glycoprotein (MOG) is a surface marker of oligodendrocyte maturation.

Authors:  N J Scolding; S Frith; C Linington; B P Morgan; A K Campbell; D A Compston
Journal:  J Neuroimmunol       Date:  1989-05       Impact factor: 3.478

9.  In vivo and in vitro evidence of cell recovery from complement attack in rheumatoid synovium.

Authors:  B P Morgan; R H Daniels; M J Watts; B D Williams
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

10.  Peripheral demyelination and remyelination initiated by the calcium-selective ionophore ionomycin: in vivo observations.

Authors:  K J Smith; S M Hall
Journal:  J Neurol Sci       Date:  1988-01       Impact factor: 3.181

View more
  15 in total

1.  Oligodendrocytes and oligodendrocyte/type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody.

Authors:  D R Wren; M Noble
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

2.  Imaging Ca2+ changes in individual oligodendrocytes attacked by T-cell perforin.

Authors:  J Jones; S Frith; S Piddlesden; B P Morgan; D A Compston; A K Campbell; M B Hallett
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

3.  Limiting and repairing the damage in multiple sclerosis.

Authors:  A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-11       Impact factor: 10.154

4.  Release of intracellular calcium stores leads to retraction of membrane sheets and cell death in mature mouse oligodendrocytes.

Authors:  J A Benjamins; L Nedelkoska
Journal:  Neurochem Res       Date:  1996-04       Impact factor: 3.996

5.  Imaging bioluminescent indicators shows Ca2+ and ATP permeability thresholds in live cells attacked by complement.

Authors:  G B Sala-Newby; K M Taylor; M N Badminton; C M Rembold; A K Campbell
Journal:  Immunology       Date:  1998-04       Impact factor: 7.397

Review 6.  Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects.

Authors:  B P Morgan
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

Review 7.  Membrane attack by complement: the assembly and biology of terminal complement complexes.

Authors:  Cosmin A Tegla; Cornelia Cudrici; Snehal Patel; Richard Trippe; Violeta Rus; Florin Niculescu; Horea Rus
Journal:  Immunol Res       Date:  2011-10       Impact factor: 2.829

8.  Oligodendrocyte susceptibility to injury by T-cell perforin.

Authors:  N J Scolding; J Jones; D A Compston; B P Morgan
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

9.  Dorsal root ganglia cocultured with macrophages: an in vitro model to study experimental demyelination.

Authors:  W Brück; Y Brück; U Diederich; R L Friede
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

10.  Complement-induced Ca2+ influx in cultured fibroblasts is decreased by the calcium-channel antagonist nifedipine or by some bivalent inorganic cations.

Authors:  P Newsholme; A A Adogu; M A Soos; C N Hales
Journal:  Biochem J       Date:  1993-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.